Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma

- Arms, Lauren M., Duchatel, Ryan J., Jackson, Evangeline R., Sobrinho, Pedro Garcia, Dun, Matthew D., Hua, Susan

Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma

- Duchatel, Ryan J., Mannan, Abdul, Kearney, Padraic S., Smith, Nathan D., Hindley, Kate E., Cain, Jason E., André, Nicolas, La Madrid, Andres Morales, Nixon, Brett, De Iuliis, Geoffry N., Nazarian, Javad, Irish, Kathleen, Woldu, Ameha S., Alvaro, Frank, Eisenstat, DD, Beck, A, Vitanza, NA, Mueller, S, Morris, JC, Dun, Matthew D., Hawtrey, Tom, Hindley, Phoebe A., Douglas, Alicia M., Jackson, Evangeline R., Findlay, Izac J., Germon, Zacary P., Staudt, Dilana

Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies

- Findlay, Izac J., De Iuliis, Geoffry N., Duchatel, Ryan J., Jackson, Evangeline R., Vitanza, Nicholas A., Cain, Jason E., Waszak, Sebastian M., Dun, Matthew D.

Molecular characterisation of oncogenic signalling networks to develop treatment strategies for diffuse intrinsic pontine glioma

- Jackson, Evangeline R.

CAR T cell therapies for diffuse midline glioma

- Thomas, Bryce C., Staudt, Dilana E., Douglas, Alicia M., Monje, Michelle, Vitanza, Nicholas A., Dun, Matthew D.